Spectrum Pharmaceuticals Inc

SPPICIK 0000831547 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed May 1, 2023. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone 0.0001

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Spectrum Pharmaceuticals Inc

Name	Roles	Filings
Fischer Seth H. Z.	Director	2
Gustafson Kurt A	Officer	2
Lim Juhyun	Director	2
Vacirca Jeff L	Director	2
Bradrick Brittany	Director	1

Showing 6-10 of 11

Per pagePrevPage 2 of 3Next

All filings

36 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Mar 17, 2023	McGahan Keith M Chief Legal Officer	SSale	27,197	$0.796	$21,649
Feb 24, 2023	Riga Thomas J CEO & President · Director	SSale	22,402	$0.77	$17,250
Feb 24, 2023	McGahan Keith M Chief Legal Officer	SSale	18,385	$0.77	$14,156
Feb 1, 2023	Riga Thomas J CEO & President · Director	SSale	107,424	$0.66	$70,900
Feb 1, 2023	McGahan Keith M Chief Legal Officer	SSale	41,014	$0.62	$25,429

Showing 11-15 of 36

Per pagePrevPage 3 of 8Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value